Table 2 Treatment characteristics and dose volume analysis
Protocol | No. of pts. |
|---|---|
46.0Gy (RBE) /1fr/1 day | 1 |
48.0Gy (RBE)/1fr/1 day | 4 |
50.0Gy (RBE)/1fr/1 day | 8 |
52.8Gy (RBE)/4fr/4 days | 7 |
60.0Gy (RBE)/4fr/4 days | 7 |
72.0Gy (RBE)/16fr/4wks | 2 |
PTV volume (ml), median (range) | 85.3 (34.6–1319.8) |
Dosimetric factors of the lung (%), median (range) | |
V5 lung | 10.5 (3.0–34.8) |
V10 lung | 8.6 (2.6–32.8) |
V15 lung | 7.1 (2.2–27.1) |
V20 lung | 6.2 (2.0–18.0) |
V25 lung | 4.6 (1.8–16.8) |
V30lung | 4.0 (1.5–15.9) |
Mean Lung Dose | 3.5 (1.0–12.2) |